E Riley. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Clinical Trials as TopicHumansMalaria/prevention & controlMalaria Vaccines/administration & dosageMalaria Vaccines/immunologyProtozoan Proteins/administration & dosageProtozoan Proteins/immunologyRecombinant ProteinsVaccination
Substances: See more » Malaria VaccinesProtozoan ProteinsRecombinant ProteinsSPf66 protein, Plasmodium
Year: 1995 PMID: 8573301 DOI: 10.1016/0952-7915(95)80065-4
Source DB: PubMed Journal: Curr Opin Immunol ISSN: 0952-7915 Impact factor: 7.486